| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 5.637 | 70.264 | 95.322 | 129.947 | 145.839 | 121.497 | 110.457 | 131.481 | 138.340 |
| Total Income - EUR | - | 19.789 | 66.264 | 107.145 | 133.686 | 141.144 | 124.787 | 120.836 | 160.668 | 179.651 |
| Total Expenses - EUR | - | 19.156 | 53.859 | 81.410 | 88.369 | 57.533 | 60.235 | 56.028 | 100.779 | 146.120 |
| Gross Profit/Loss - EUR | - | 633 | 12.405 | 25.735 | 45.317 | 83.611 | 64.552 | 64.808 | 59.888 | 33.531 |
| Net Profit/Loss - EUR | - | 464 | 11.525 | 24.575 | 43.709 | 81.894 | 63.212 | 63.574 | 58.542 | 30.601 |
| Employees | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Hipy Bio Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 1.445 | 5.826 | 4.381 | 8.071 | 52.456 | 53.669 | 78.765 | 146.360 | 239.479 |
| Current Assets | - | 25.316 | 66.000 | 134.875 | 217.419 | 259.746 | 281.448 | 281.134 | 344.013 | 280.103 |
| Inventories | - | 18.114 | 16.798 | 27.281 | 25.601 | 18.322 | 15.273 | 14.774 | 62.711 | 46.598 |
| Receivables | - | 6.464 | 17.106 | 22.204 | 14.433 | 40.843 | 38.551 | 27.490 | 47.357 | 169.146 |
| Cash | - | 738 | 32.096 | 20.923 | 19.337 | 14.520 | 5.258 | 4.662 | 233.946 | 26.263 |
| Shareholders Funds | - | 508 | 12.025 | 36.379 | 79.384 | 159.773 | 219.441 | 283.696 | 341.378 | 376.303 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 26.414 | 59.947 | 102.877 | 146.179 | 152.470 | 115.746 | 81.457 | 120.788 | 103.006 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28.207 | 40.322 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1032 - 1032" | |||||||||
| CAEN Financial Year |
1032
|
|||||||||
Comments - Hipy Bio Srl